Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Are Insiders Ditching Shares Of These Companies?

Page 1 of 2

Insider trading activity has been diminishing over the past few weeks with the kick-off of the third quarter earnings season. Insider buying activity weakened significantly during the previous trading week, while insider selling was weak as well. Statistics reveal that the ratio of insider buying to insider selling decreased last week, which implies that insiders were selling at a greater rate in comparison to buying than previously. Of course, this is not necessarily a good sign for the U.S equity markets, as insiders’ trades might be pointing to dwindling confidence in their companies’ prospects. Even so, one should not forget that insiders might sell stock for numerous reasons unrelated to their companies’ outlook, so the decreasing insider buying/selling ratio should not be directly interpreted as a bearish sign. Moving on to the underlying purpose of this article, the Insider Monkey team pinpointed three companies with an unusual volume of insider selling, so we will attempt to stipulate whether these sales were driven by any firm-specific issues and what that might mean for other investors.

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35%-to-45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned more than 102% over the ensuing three years, outperforming the S&P 500 Index by more than 53 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

Let’s begin our discussion with Finish Line Inc. (NASDAQ:FINL), a specialty retailer of athletic shoes, apparel, and accessories. Samuel M. Sato, who has served as President since October 2014, reported selling 5,565 shares last Wednesday at a price of $18.89 per share. The company’s President currently owns 40,756 shares valued at approximately $761,300. The shares of Finish Line Inc. (NASDAQ:FINL) are 23% in the red year-to-date, mainly owing to the disappointing second quarter earnings report the company released at the end of September. The retailer posted net sales of $483.2 million, which increased 3.5% year-over-year. At the same time, the company’s diluted earnings per share came to $0.57, compared to $0.54 reported a year ago. However, these figures were not well received by the market, which expected greater top-line growth. Earlier this month, Goldman Sachs Group Inc. (NYSE:GS) upgraded the stock to “Neutral” from “Sell”, with a price target of $20.00. Balyasny Asset Management, founded by Dmitry Balyasny, added an 830,872-share position in Finish Line Inc. (NASDAQ:FINL) to its portfolio during the June quarter.

Follow Finish Line Inc (NASDAQ:FINL)
Trade (NASDAQ:FINL) Now!

The next page will discuss the insider trading at the other two companies mentioned above, one of which will disclose its third quarter earnings report today after the market closes.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!